BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S financial statements, including revenue, expenses, profit, and loss

The total revenue of BXP for the last quarter is 78.97 M GBP, and it's 0.98% lower compared to the previous quarter. The net income of Q3 24 is 9.81 M GBP.